Platform

  • Search
  • Seminars
  • Conferences
  • Jobs

Resources

  • Submit Content
  • About Us

© 2025 World Wide

Open knowledge for all • Started with World Wide Neuro • A 501(c)(3) Non-Profit Organization

Analytics consent required

World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.

Review the Privacy Policy for details about analytics processing.

World Wide
SeminarsConferencesWorkshopsCoursesJobsMapsFeedLibrary
Back to SeminarsBack
SeminarPast EventNeuroscience

SCN1A/Nav1.1 sodium channel: loss and gain of function in epilepsy and migraine

Massimo Mantegazza

Prof

Institute of Molecular and Cellular Pharmacology (IPMC) CNRS UMR7275 and University Côte d'Azur

Schedule
Wednesday, April 21, 2021

Showing your local timezone

Schedule

Wednesday, April 21, 2021

5:00 PM Europe/London

Host: Clinical and Experimental Epilepsy

Access Seminar

Event Information

Domain

Neuroscience

Original Event

View source

Host

Clinical and Experimental Epilepsy

Duration

70 minutes

Abstract

Genetic mutations of the SCN1A gene, the voltage gated sodium channel NaV1.1, cause well-defined epilepsies, including the severe developmental and epileptic encephalopathy Dravet syndrome and genetic epilepsy with febrile seizures plus (GEFS+), as well as a severe form of migraine with aura, familial hemiplegic migraine (FHM). More recently, they have been identified in an extremely severe early infantile encephalopathy. Functional studies and animal models have contributed to disclose pathological mechanisms, which can be often linked to a straightforward loss- vs gain- of channel function. However, although this simple dichotomy is pertinent and useful, detailed pathological mechanisms in neuronal circuits can be more complex, sometimes because of unexpected homeostatic or pathologic responses. I will compare pathological mechanisms of epilepsy and migraine mutations studied with cellular, animal and computational models, highlighting a novel homeostatic response implemented by CCK-positive GABAergic neurons in a mouse model of Dravet syndrome, which may be boosted in therapeutic approaches.

Topics

GABAergic neuronsSCN1Adravetdravet syndromeepilepsyfamilial hemiplegic migrainegenetic epilepsyhomeostatic responsemigrainenav11sodium channels

About the Speaker

Massimo Mantegazza

Prof

Institute of Molecular and Cellular Pharmacology (IPMC) CNRS UMR7275 and University Côte d'Azur

Contact & Resources

Personal Website

www.ipmc.cnrs.fr/cgi-bin/site.cgi

Related Seminars

Seminar60%

Knight ADRC Seminar

neuro

Jan 20, 2025
Washington University in St. Louis, Neurology
Seminar60%

TBD

neuro

Jan 20, 2025
King's College London
Seminar60%

Guiding Visual Attention in Dynamic Scenes

neuro

Jan 20, 2025
Haifa U
January 2026
Full calendar →